By Adam J. Fein, Ph.D.
We had an absolutely incredible time at the second annual Drug Channels Leadership Forum (DCLF)!
Despite some travel challenges, we still filled the room for a sold-out event packed with thought-provoking discussions, candid insights, and dynamic exchanges about the forces shaping the drug channel. The 340B session was legendary!
We are grateful to everyone who took the stage to share their insights and to all who participated in making this event so impactful. A huge thank you to our speakers for sharing their expertise and unfiltered perspectives—and to everyone in the room for making the conversations so engaging.
I had the privilege of speaking on stage with leaders from AstraZeneca, Boehringer Ingelheim, Cardinal Health, 46Brooklyn, Nephron Research, and Prime Therapeutics.
And Mark Cuban wrapped up the first day with his unfiltered and highly entertaining take on U.S. healthcare. (Spoiler: He had a few opinions.)
Click here to see a selfie of Mark and me from the stage.
I also had the privilege of introducing the Drug Channels Institute team, seven members of whom attended the event.
Two of DCI’s newest team members—Tyler Novotny and Bryce Platt—each moderated panels.
You can find more photos by searching for #DCLF2026 on LinkedIn.
BTW, you won’t see any news stories about the DCLF. That’s because the media were not invited and the sessions were not recorded. No livestreams. No transcripts. You had to be in the room where it happened.đŸ˜‰
The DCLF will return in March 2027.
P.S. A special shoutout to the phenomenal HMP Global team, who delivered a truly first-class experience for nearly 400 attendees. Your hard work and dedication made this event unforgettable!
Drug Channels delivers timely analysis and provocative opinions from Adam J. Fein, Ph.D., the country's foremost expert on pharmaceutical economics and the drug distribution system. Drug Channels reaches an engaged, loyal and growing audience of more than 100,000 subscribers and followers. Learn more...
Showing posts with label DCI In-Person Events. Show all posts
Showing posts with label DCI In-Person Events. Show all posts
Wednesday, March 25, 2026
Tuesday, January 06, 2026
Drug Channels Leadership Forum 2026: Request an Invitation Before It’s Too Late!
The 2026 Drug Channels Leadership Forum (DCLF) is coming soon! Our second annual event will take place March 16–18, 2026, at the Turnberry Resort & Spa in Miami.
Once again, Drug Channels Institute (DCI) is proud to host this invite-only gathering of senior leaders across the drug channel ecosystem. You must request an invitation to be considered for attendance. Our final wave of invitations will begin in mid-January. The 2026 program features in-depth fireside chats with me, along with dynamic panel discussions led by an exceptional group of executives and subject matter experts. View the full 2026 Drug Channels Leadership Forum agenda.
Our 2026 speaker lineup brings together a diverse group of C-suite executives, policymakers, and industry thought leaders—ensuring every session delivers candid, high-value insights you won’t hear anywhere else.
DCLF is a strategic, invite-only gathering for leaders from across the healthcare and pharmaceutical landscape, including:
To maintain the event’s strategic focus, attendance from industry suppliers (e.g., technology, consulting, financial services, etc.) is available only through sponsorship. Each sponsorship level includes a limited number of attendee badges, ensuring a highly curated and balanced group of participants.
Expect another year of bold, candid discussions—this is not a conference of scripted presentations. We’ve enhanced the 2026 agenda with new formats and even more opportunities for direct, high-impact exchanges among attendees.
At DCLF, there are no exhibit halls, no press, no recordings, and no distractions—just substance and strategy.
You can expect:
Have questions? Please contact us.
We look forward to welcoming you to Miami in March 2026.
Once again, Drug Channels Institute (DCI) is proud to host this invite-only gathering of senior leaders across the drug channel ecosystem. You must request an invitation to be considered for attendance. Our final wave of invitations will begin in mid-January. The 2026 program features in-depth fireside chats with me, along with dynamic panel discussions led by an exceptional group of executives and subject matter experts. View the full 2026 Drug Channels Leadership Forum agenda.
MEET THE SPEAKERS
Our 2026 speaker lineup brings together a diverse group of C-suite executives, policymakers, and industry thought leaders—ensuring every session delivers candid, high-value insights you won’t hear anywhere else.
WHO SHOULD ATTEND
DCLF is a strategic, invite-only gathering for leaders from across the healthcare and pharmaceutical landscape, including:
- Pharmaceutical manufacturers
- PBMs, health plans, employers, and plan sponsors
- Health systems and physician practices
- Pharmacies and wholesalers
- Policymakers
To maintain the event’s strategic focus, attendance from industry suppliers (e.g., technology, consulting, financial services, etc.) is available only through sponsorship. Each sponsorship level includes a limited number of attendee badges, ensuring a highly curated and balanced group of participants.
WHAT TO EXPECT
Expect another year of bold, candid discussions—this is not a conference of scripted presentations. We’ve enhanced the 2026 agenda with new formats and even more opportunities for direct, high-impact exchanges among attendees.
At DCLF, there are no exhibit halls, no press, no recordings, and no distractions—just substance and strategy.
You can expect:
- Provocative panels with C-suite executives
- Off-the-record insights and open Q&A sessions
- Meaningful peer-to-peer dialogue in an intimate setting
GET STARTED
Our final wave of invitations will begin in mid-January. You must request an invitation to be considered for attendance.Have questions? Please contact us.
We look forward to welcoming you to Miami in March 2026.
Labels:
DCI In-Person Events
Thursday, December 18, 2025
Drug Channels News Roundup, December 2025: The Net Pricing Drug Channel (#NPDC) Era, LillyDirect, My $0.02 on New MFPs, PBMs in Medicaid—and DCLF 2026
Happy New Year, everyone!
As always, thank you for welcoming Drug Channels into your inboxes, browsers, and apps. I’m continually inspired by the diverse and thoughtful people who follow, share, and challenge our work. Our DCI community now includes more than 110,000 subscribers and followers across the industry. If you haven't already done so, you can stay connected by signing up for an email subscription or following me on LinkedIn.
We loved bringing you our analysis and curated links throughout 2025, and we hope you enjoyed engaging with us—and with one another—across the DCI community.
Stay tuned! In addition to our second Drug Channels Leadership Forum, we have several exciting announcements coming your way in 2026.
Wishing you and your family health and happiness,
Adam and the DCI team
In our final roundup of 2025: Plus: We're getting ready for the second Drug Channels Leadership Forum! Have you submitted your invite request yet?
P.S. Join my nearly 67,000 LinkedIn followers for daily links to neat stuff, along with sharp and thoughtful commentary from the DCI community.
As always, thank you for welcoming Drug Channels into your inboxes, browsers, and apps. I’m continually inspired by the diverse and thoughtful people who follow, share, and challenge our work. Our DCI community now includes more than 110,000 subscribers and followers across the industry. If you haven't already done so, you can stay connected by signing up for an email subscription or following me on LinkedIn.
We loved bringing you our analysis and curated links throughout 2025, and we hope you enjoyed engaging with us—and with one another—across the DCI community.
Stay tuned! In addition to our second Drug Channels Leadership Forum, we have several exciting announcements coming your way in 2026.
Wishing you and your family health and happiness,
Adam and the DCI team
In our final roundup of 2025: Plus: We're getting ready for the second Drug Channels Leadership Forum! Have you submitted your invite request yet?
P.S. Join my nearly 67,000 LinkedIn followers for daily links to neat stuff, along with sharp and thoughtful commentary from the DCI community.
Tuesday, September 09, 2025
Drug Channels Leadership Forum 2026: Full Agenda Now Available (Spoiler: Even more awesome than 2025!)
We’re thrilled to announce the full agenda for the 2026 Drug Channels Leadership Forum (DCLF)—taking place from March 16–18, 2026, at the Turnberry Resort & Spa in Miami. Once again, Drug Channels Institute (DCI) is proud to host this invite-only gathering of senior leaders across the drug channel ecosystem. You must request an invitation to be considered for attendance. We will begin sending invitations in mid-October.
The 2026 program features fireside chats with me, plus dynamic panel discussions led by an exceptional group of executives and subject matter experts. View the full 2026 Drug Channels Leadership Forum agenda.
MEET THE SPEAKERS
Our 2026 lineup brings together a diverse range of C-suite leaders and policy influencers, ensuring every session delivers candid, high-value insights.
WHO SHOULD ATTEND
DCLF is a strategic, invite-only gathering for leaders from across the healthcare and pharmaceutical landscape, including:
Expect another year of bold, candid discussions—not just presentations. We’ve enhanced the 2026 agenda with new formats and even more opportunities for direct, high-impact exchanges among attendees.
At DCLF, there are no exhibit halls, no press, no recordings, and no distractions—just substance and strategy.
You can expect:
SPONSORSHIP OPPORTUNITIES
To maintain the event’s strategic focus, attendance from industry suppliers (e.g., technology, consulting, financial services, etc.) is available only through sponsorship.
Each sponsorship level provides a limited number of attendee badges, ensuring the right mix of participants. WATCH HIGHLIGHTS FROM DCLF 2025
Relive the #DCLF2025 energy and hear testimonials directly from participants.
GET STARTED
Invitations will begin going out in mid-October 2025. You must request an invitation to be considered for attendance. Don’t wait—our curated guest list fills up fast.
Have questions? Interested in sponsorship? Please contact us.
We can’t wait to welcome you to Miami in 2026!
MEET THE SPEAKERS
Our 2026 lineup brings together a diverse range of C-suite leaders and policy influencers, ensuring every session delivers candid, high-value insights.
WHO SHOULD ATTEND
DCLF is a strategic, invite-only gathering for leaders from across the healthcare and pharmaceutical landscape, including:
- Pharmaceutical manufacturers
- PBMs, health plans, employers, and plan sponsors
- Health systems and physician practices
- Pharmacies and wholesalers
- Policymakers
Expect another year of bold, candid discussions—not just presentations. We’ve enhanced the 2026 agenda with new formats and even more opportunities for direct, high-impact exchanges among attendees.
At DCLF, there are no exhibit halls, no press, no recordings, and no distractions—just substance and strategy.
You can expect:
- Provocative panels with C-suite executives
- Off-the-record insights and open Q&A sessions
- Direct, high-impact exchanges among leaders
SPONSORSHIP OPPORTUNITIES
To maintain the event’s strategic focus, attendance from industry suppliers (e.g., technology, consulting, financial services, etc.) is available only through sponsorship.
Each sponsorship level provides a limited number of attendee badges, ensuring the right mix of participants. WATCH HIGHLIGHTS FROM DCLF 2025
Relive the #DCLF2025 energy and hear testimonials directly from participants.
(Can’t see the video above? Click here.)
GET STARTED
Invitations will begin going out in mid-October 2025. You must request an invitation to be considered for attendance. Don’t wait—our curated guest list fills up fast.
Have questions? Interested in sponsorship? Please contact us.
We can’t wait to welcome you to Miami in 2026!
Labels:
DCI In-Person Events
Thursday, April 24, 2025
SAVE THE DATE: Drug Channels Leadership Forum, March 16-18, 2026
After a blockbuster inaugural event and tremendous feedback from attendees, we’re excited to announce that the Drug Channels Leadership Forum (DCLF) returns on March 16–18, 2026, at the Turnberry Resort & Spa in Miami. This one-of-a-kind, off-the-record event convenes senior leaders across the drug channel to address today’s most pressing industry issues.
DCLF is an invite-only, strategic gathering for leaders across the drug channel ecosystem, including:
Expect bold, candid discussions—not just presentations. We’re enhancing the 2026 agenda with new formats and even more opportunities for direct, high-impact exchanges among attendees.
Here’s a glimpse of what made the 2025 event such a success:
Relive the #DCLF2025 energy and hear testimonials directly from participants.
SPONSORSHIP OPPORTUNITIES
We limit attendance from industry suppliers (e.g., tech, consulting, financial services) to maintain the event’s strategic focus.
Attendance for suppliers is only available through sponsorship. The number of badges provided depends on your selected sponsorship level.
To foster open dialogue and protect attendee confidentiality, DCLF is a private event:
GET STARTED
Invitations will begin going out in October 2025. Don’t wait—our curated guest list fills up fast.
Have questions? Interested in sponsorship? Please contact us or visit us at booth #1601 at Asembia.
“I’d recommend the DCLF to anyone in the drug industry in the US. It's a great opportunity to bring together all constituents and members and have a frank sharing of ideas.”WHO SHOULD ATTEND
— Timothy Folts, Finance Director of Gross-to-Net Strategy, GSK
DCLF is an invite-only, strategic gathering for leaders across the drug channel ecosystem, including:
- Pharmaceutical manufacturers
- PBMs, health plans, and employers
- Health systems and physician practices
- Pharmacies and wholesalers
- Policymakers
“The thing that I think sets it apart is the fact that there are so many different parts of the industry that are represented here.”WHAT TO EXPECT
— Jeanine Robertson, Director of Pharmacy Network Relations, Liviniti
Expect bold, candid discussions—not just presentations. We’re enhancing the 2026 agenda with new formats and even more opportunities for direct, high-impact exchanges among attendees.
Here’s a glimpse of what made the 2025 event such a success:
- Provocative panels with C-suite executives
- Off-the-record insights and open Q&A sessions
- No exhibit hall, no press, no distractions—just substance
✅ 92% of 2025 attendees said they'd return!
“Sometimes you go to events like this and the chat on stage is completely pre-scripted. But we're not seeing that today, which has really added a robustness and flavor to the overall discussion.”WATCH HIGHLIGHTS FROM DCLF 2025
— Jason Dombi, Senior Vice President of Strategic Solutions, Cencora
Relive the #DCLF2025 energy and hear testimonials directly from participants.
(Can’t see the video above? Click here.)
SPONSORSHIP OPPORTUNITIES
We limit attendance from industry suppliers (e.g., tech, consulting, financial services) to maintain the event’s strategic focus.
Attendance for suppliers is only available through sponsorship. The number of badges provided depends on your selected sponsorship level.
“The networking opportunities at DCLF have been impressive.”A CONFIDENTIAL, INVITE-ONLY EXPERIENCE
— Angie Franks, CEO, Kalderos
To foster open dialogue and protect attendee confidentiality, DCLF is a private event:
- No media or press
- No recording or reporting
- No exhibit hall
GET STARTED
Invitations will begin going out in October 2025. Don’t wait—our curated guest list fills up fast.
Have questions? Interested in sponsorship? Please contact us or visit us at booth #1601 at Asembia.
Monday, April 21, 2025
Visit Drug Channels in Booth #1601 at #Asembia25 for a Special “Ask Adam Anything” (#AAA) Session
Next week, the Drug Channels Institute (DCI) team will be heading to Asembia’s AXS25 Summit at the always fabulous Wynn Las Vegas.
Thanks to our friends at HMP Global, we’re thrilled to have our very own DCI booth once again!
As you might expect, we'll be showing up in true Drug Channels style. Be sure to swing by booth #1601 for fun, flair, and pharma-frivolity:
DCI’s booth is conveniently located in the middle of the hall. Check out the handy map below for directions:
And remember: What happens in Booth #1601, stays in Booth #1601. đŸ˜‰
Thanks to our friends at HMP Global, we’re thrilled to have our very own DCI booth once again!
As you might expect, we'll be showing up in true Drug Channels style. Be sure to swing by booth #1601 for fun, flair, and pharma-frivolity:
- Ask Adam Anything (#AAA). Join DCI president Adam J. Fein, Ph.D., for a special live session during the opening reception on Monday, April 28, at 4:00 p.m. Bring your phone—selfies encouraged!
- Spin the Drug Channels Wheel O’ Fun and win fabulous prizes!
- Request your invitation to the 2026 Drug Channels Leadership Forum! (ICYMI, check out Reflections and Photos from the Inaugural Drug Channels Leadership Forum 2025.)
- Chat with the marvelous Paula Fein, DCI’s intrepid vice president of business development, about sponsorship opportunities for the Drug Channels Leadership Forum 2026!
- Meet Jeana Dollear, the behind-the-scenes dynamo who keeps everything running smoothly.
- Enjoy cupcakes and conversation!
[Click to Enlarge]
And remember: What happens in Booth #1601, stays in Booth #1601. đŸ˜‰
Labels:
DCI In-Person Events,
Fun Stuff,
Specialty Drugs
Wednesday, March 26, 2025
Drug Channels News Roundup, March 2025: PBM Unbundling Update, Stelara Biosimilar Price War, My $0.02 on the Optum Rx News, Follow the Dollar, and #DCLF2025
Spring has officially arrived in sunny downtown Philadelphia—the proud home base of Drug Channels. As you can see on the right, we celebrated in Miami at the Drug Channels Leadership Forum.
The vernal equinox also brought a surprising surge of industry updates and noteworthy news you won’t want to miss:
P.S. Join my more than 61,000 LinkedIn followers for daily links to neat stuff along with thoughtful and provocative commentary from the DCI community.
The vernal equinox also brought a surprising surge of industry updates and noteworthy news you won’t want to miss:
- The Stelara biosimilar price war begins
- My reaction to Optum Rx’s pharmacy reimbursement announcement
- A valuable Follow the Dollar primer
P.S. Join my more than 61,000 LinkedIn followers for daily links to neat stuff along with thoughtful and provocative commentary from the DCI community.
Coming soon: PBM Industry Update: Trends, Challenges, and What’s Ahead. Our first webinar of the year will tackle the most controversial drug channel participants. Join Adam J. Fein, Ph.D., on April 4, 2025, from 12:00 p.m. to 1:30 p.m. ET, as he shares his expert analysis on critical industry developments. Click here to learn more and sign up.
Tuesday, March 25, 2025
Reflections and Photos from the Inaugural Drug Channels Leadership Forum 2025
Wow! What an absolutely incredible time at the inaugural Drug Channels Leadership Forum (DCLF)!
Paula and I are beyond grateful to everyone who took the stage to share their insights and to all who participated in making this event so impactful. (Even Paula got on the main stage!) The event was packed with thought-provoking discussions, candid insights, and dynamic exchanges. The HMP Global team delivered a truly first-class experience for the nearly 350 lucky attendees.
Here are some brief video highlights. Click here if you can't see the video below.
We also had a professional photographer. Here's what happened in the morning of the first day.
You can see more fun photos from the event here on my LinkedIn account:
You can find attendees’ photos by searching “#DCLF2025” on LinkedIn. (Be sure to use quotation marks and then sort by “Latest.”)
BTW, you won’t see any news stories about the DCLF. That’s because the media were not invited and the sessions were not recorded. You had to be in the room where it happened.đŸ˜‰
The DCLF will return in March 2026.
P.S. A special shoutout to the phenomenal HMP Global team. Your hard work and dedication made this event unforgettable!
Paula and I are beyond grateful to everyone who took the stage to share their insights and to all who participated in making this event so impactful. (Even Paula got on the main stage!) The event was packed with thought-provoking discussions, candid insights, and dynamic exchanges. The HMP Global team delivered a truly first-class experience for the nearly 350 lucky attendees.
Here are some brief video highlights. Click here if you can't see the video below.
We also had a professional photographer. Here's what happened in the morning of the first day.
[Click to Enlarge]
You can see more fun photos from the event here on my LinkedIn account:
You can find attendees’ photos by searching “#DCLF2025” on LinkedIn. (Be sure to use quotation marks and then sort by “Latest.”)
BTW, you won’t see any news stories about the DCLF. That’s because the media were not invited and the sessions were not recorded. You had to be in the room where it happened.đŸ˜‰
The DCLF will return in March 2026.
P.S. A special shoutout to the phenomenal HMP Global team. Your hard work and dedication made this event unforgettable!
[Click to Enlarge]
Monday, January 13, 2025
Drug Channels Leadership Forum: Request an Invitation Before It’s Too Late!
The inaugural Drug Channels Leadership Forum (DCLF) is coming soon! This exclusive event will be held from March 17 to 19, 2025, at the Turnberry Resort and Spa in Miami.
Our first event will provide attendees with an opportunity to explore the most pressing strategic issues and crucial uncertainties that will impact all participants across U.S. drug channels.
Speakers and panelists include top industry executives and subject matter experts from throughout the drug channel. Registered attendees include senior executives from pharmaceutical manufacturers, pharmacy benefit managers, health systems, physician practices, pharmacies, wholesalers, and more.
To maximize the value of networking and learning, the event will have a limited number of senior-level participants. We have a small number of spots still available for qualified individuals. You must submit a request to be considered for an invitation to attend.
Everyone here at Drug Channels Institute (DCI) is excited to bring this novel event to the drug channels community. Visit the event website for more information on the registration process and our policies.
Below, I have reproduced our original press release. I hope you can join us!
Our first event will provide attendees with an opportunity to explore the most pressing strategic issues and crucial uncertainties that will impact all participants across U.S. drug channels.
Speakers and panelists include top industry executives and subject matter experts from throughout the drug channel. Registered attendees include senior executives from pharmaceutical manufacturers, pharmacy benefit managers, health systems, physician practices, pharmacies, wholesalers, and more.
To maximize the value of networking and learning, the event will have a limited number of senior-level participants. We have a small number of spots still available for qualified individuals. You must submit a request to be considered for an invitation to attend.
- View the full Drug Channels Leadership Forum agenda. It’s filled with senior industry executives who will participate in fireside chats with me as well as topical panel discussions moderated by a diverse set of subject matter experts.
- Click here to request an invitation to attend. DCI will carefully review all submissions to include participants from a broad range of organizations. We are extending invitations on a rolling basis. Once you receive your invitation, you will have 15 business days to accept and complete the registration by paying the registration fee.
Everyone here at Drug Channels Institute (DCI) is excited to bring this novel event to the drug channels community. Visit the event website for more information on the registration process and our policies.
Below, I have reproduced our original press release. I hope you can join us!
Tuesday, September 10, 2024
Drug Channels Leadership Forum: Full Agenda Now Available (Spoiler: It’s Awesome!)
I am pleased to announce the full agenda for the inaugural Drug Channels Leadership Forum, which will be held from March 17 to 19, 2025, at the Turnberry Resort and Spa in Miami. Everyone here at Drug Channels Institute (DCI) is excited to bring this novel event to the drug channels community.
I personally assembled the agenda. As you can see, it’s filled with senior industry executives who will participate in fireside chats with me as well as topical panel discussions moderated by a diverse set of subject matter experts.
I am also pleased to announce an excellent addition to the agenda. David Joyner, Executive Vice President, CVS Health, and President, CVS Caremark, and Prem Shah, Executive Vice President and Chief Pharmacy Officer, CVS Health and President, Pharmacy and Consumer Wellness, will be joining me for a fireside chat.
To maximize the value of networking and learning, the event will have fewer than 450 participants. If you haven’t done so yet, click here to request an invitation. DCI will carefully review all submissions to include participants from a broad range of industry organizations. DCI will begin extending invitations on a rolling basis starting on September 23, 2024. Once you receive your invitation, you will have 15 business days to accept and complete the registration by paying the registration fee.
Please note that the number of attendees from technology companies, business services, and other industry vendors will be strictly limited to the number of badges included with their chosen sponsorship level. There will be no exhibit hall and no media. Click here to learn more about available sponsorship opportunities.
Visit the event website for more information on the registration process and our policies.
Read on for the full press release. I hope you can join us!
I personally assembled the agenda. As you can see, it’s filled with senior industry executives who will participate in fireside chats with me as well as topical panel discussions moderated by a diverse set of subject matter experts.
I am also pleased to announce an excellent addition to the agenda. David Joyner, Executive Vice President, CVS Health, and President, CVS Caremark, and Prem Shah, Executive Vice President and Chief Pharmacy Officer, CVS Health and President, Pharmacy and Consumer Wellness, will be joining me for a fireside chat.
To maximize the value of networking and learning, the event will have fewer than 450 participants. If you haven’t done so yet, click here to request an invitation. DCI will carefully review all submissions to include participants from a broad range of industry organizations. DCI will begin extending invitations on a rolling basis starting on September 23, 2024. Once you receive your invitation, you will have 15 business days to accept and complete the registration by paying the registration fee.
Please note that the number of attendees from technology companies, business services, and other industry vendors will be strictly limited to the number of badges included with their chosen sponsorship level. There will be no exhibit hall and no media. Click here to learn more about available sponsorship opportunities.
Visit the event website for more information on the registration process and our policies.
Read on for the full press release. I hope you can join us!
Labels:
DCI In-Person Events,
Industry Trends
Monday, June 24, 2024
Meet the Four Executives Headlining the Drug Channels Leadership Forum
Good news, everyone! We have secured four outstanding fireside chat participants for our inaugural Drug Channels Leadership Forum, which will be held next March in Miami.
I’ll be leading one-on-one conversations with each of these executives:
The event will also include panel discussions covering a range of important topics. Participants in these panels will be announced this fall.
IMPORTANT: To maximize the value of networking and learning, the event will have a limited number of attendees. Click here to request an invitation.
We will also have a limited number of sponsors. Click here to learn more about sponsorship opportunities.
Read on for the full press release. Hope you can join us!
I’ll be leading one-on-one conversations with each of these executives:
- Steven H. Collis, Chairman, President, and CEO, Cencora, Inc.
- Patrick Conway, MD, MSc, CEO, Optum Rx
- Frank Cunningham, Group Vice President, Global Value and Access & Lilly Direct, Eli Lilly and Company
- Tim Wentworth, CEO, Walgreens Boots Alliance, Inc.
The event will also include panel discussions covering a range of important topics. Participants in these panels will be announced this fall.
IMPORTANT: To maximize the value of networking and learning, the event will have a limited number of attendees. Click here to request an invitation.
We will also have a limited number of sponsors. Click here to learn more about sponsorship opportunities.
Read on for the full press release. Hope you can join us!
Labels:
DCI In-Person Events,
Industry Trends
Monday, April 08, 2024
SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025
I am pleased to announce the inaugural Drug Channels Leadership Forum! This unique, new event will be held from March 17 to 19, 2025, at the Turnberry Resort and Spa in Miami.
The Leadership Forum will be an executive gathering where drug channel leaders can network and discuss key issues and challenges facing the commercial healthcare system. We intend to bring together people from the entire drug channel: pharmaceutical manufacturers, pharmacy benefit managers (PBMs), health plans, insurers, and plan sponsors, wholesalers and distributors, pharmacies, providers, buying groups, government officials, and more.
I’m personally assembling the agenda, which will be a mix of one-on-one fireside chats with industry leaders combined with hard-hitting, topical panel discussions. And of course, I'll be there to moderate the entire event and lead the fireside chats. Thanks to DCI’s partnership with HMP Global, we can bring this novel event to the drug channels community.
To maximize the value of networking and learning, the event will have a limited number of attendees. Click here to request an invitation.
We will also have a very limited number of sponsors. Click here to learn more about sponsorship opportunities.
Read on for the full press release. Hope you can join us!
The Leadership Forum will be an executive gathering where drug channel leaders can network and discuss key issues and challenges facing the commercial healthcare system. We intend to bring together people from the entire drug channel: pharmaceutical manufacturers, pharmacy benefit managers (PBMs), health plans, insurers, and plan sponsors, wholesalers and distributors, pharmacies, providers, buying groups, government officials, and more.
I’m personally assembling the agenda, which will be a mix of one-on-one fireside chats with industry leaders combined with hard-hitting, topical panel discussions. And of course, I'll be there to moderate the entire event and lead the fireside chats. Thanks to DCI’s partnership with HMP Global, we can bring this novel event to the drug channels community.
To maximize the value of networking and learning, the event will have a limited number of attendees. Click here to request an invitation.
We will also have a very limited number of sponsors. Click here to learn more about sponsorship opportunities.
Read on for the full press release. Hope you can join us!
Labels:
DCI In-Person Events,
Industry Trends



.png)











